Early Diagnosis and Successful Treatment of Influenza Coinfection With Community-Onset Methicillin-Resistant

Po-Kai Chan1,2, Chun-Han Wu1,3

  • 1Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, ndmctsgh.edu.tw.

Abstract

Insights

Rapid molecular diagnostics accurately identified coinfections in necrotizing pneumonia, leading to timely treatment and favorable outcomes. Early pathogen detection is crucial for managing severe respiratory infections.

Area of Science:

  • Infectious Diseases
  • Molecular Diagnostics
  • Pulmonology

Background:

  • Necrotizing pneumonia is a severe complication of community-acquired pneumonia.
  • It is often caused by toxin-producing or drug-resistant pathogens.
  • Rapid pathogen identification is critical for effective treatment.

Purpose of the Study:

  • To highlight the role of rapid molecular diagnostics in identifying coinfections in necrotizing pneumonia.
  • To emphasize the impact of timely diagnosis and targeted therapy on patient outcomes.
  • To advocate for the integration of PCR-based diagnostics in managing severe pneumonia.

Main Methods:

  • Case report of a female adult with necrotizing pneumonia.
  • Utilized the BioFire FilmArray pneumonia panel for rapid pathogen detection.
  • Initial testing identified coinfection with influenza and methicillin-resistant Staphylococcus aureus (MRSA).

Main Results:

  • The BioFire FilmArray provided rapid and precise identification of influenza and MRSA coinfection.
  • The patient experienced worsening respiratory failure, requiring mechanical ventilation.
  • Early diagnosis and targeted antimicrobial therapy led to significant clinical improvement and recovery.

Conclusions:

  • Rapid molecular diagnostics are critical for early detection of coinfections in necrotizing pneumonia.
  • Timely identification of pathogens like influenza and MRSA enables targeted antimicrobial therapy.
  • Integrating PCR-based diagnostics into clinical practice can improve management and outcomes for severe pneumonia.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...